Your browser doesn't support javascript.
loading
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen.
Marin, Maximo J; Mathew, Carol M; Rajasekhar, Anita; Zumberg, Marc; Euliano, Tammy Y; Winter, William E; Pelletier, J Peter R; Pruitt, Heather D; Harris, Neil S.
Afiliação
  • Marin MJ; Department of Pathology, Immunology and Laboratory Medicine.
  • Mathew CM; Division of Hematology-Oncology, Department of Medicine.
  • Rajasekhar A; Division of Hematology-Oncology, Department of Medicine.
  • Zumberg M; Division of Hematology-Oncology, Department of Medicine.
  • Euliano TY; Department of Anesthesiology.
  • Winter WE; Department of Obstetrics and Gynecology, University of Florida College of Medicine.
  • Pelletier JPR; Department of Pathology, Immunology and Laboratory Medicine.
  • Pruitt HD; Department of Pathology, Immunology and Laboratory Medicine.
  • Harris NS; Department of Anesthesiology.
Blood Coagul Fibrinolysis ; 34(5): 337-344, 2023 Jul 01.
Article em En | MEDLINE | ID: mdl-37395199
Inherited dysfibrinogenemias are molecular disorders of fibrinogen that affect fibrin polymerization. The majority of cases are asymptomatic, but a significant proportion suffer from increased bleeding or thrombosis. We present two unrelated cases of dysfibrinogenemia, both of whom showed a characteristic discrepancy between fibrinogen activity and the immunologic fibrinogen. In one patient, the dysfibrinogenemia was confirmed by molecular analysis; in the other case, the diagnosis was presumptive based upon laboratory studies. Both patients underwent elective surgery. Both received a highly purified fibrinogen concentrate preoperatively and demonstrated a suboptimal laboratory response to the infusion. Three methods for determining fibrinogen concentration (Clauss fibrinogen, prothrombin-derived fibrinogen, and the viscoelastic functional fibrinogen) were utilized in the case of one patient, and these techniques showed discrepant results with the classic Clauss method giving the lowest concentration. Neither patient experienced excessive bleeding during surgery. Although these discrepancies have been previously described in untreated patients, their manifestation after infusion of purified fibrinogen is less well appreciated.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Trombose / Hemostáticos / Afibrinogenemia Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Revista: Blood Coagul Fibrinolysis Assunto da revista: ANGIOLOGIA / HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Trombose / Hemostáticos / Afibrinogenemia Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Revista: Blood Coagul Fibrinolysis Assunto da revista: ANGIOLOGIA / HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article